For psoriasis, four out of five clinical studies showed significant improvements in skin condition and weight loss
Ipamorelin has a cleaner side effect profile
In this context, glucagon-like peptide-1 receptor (GLP-1R) agonists have been increasingly used in the treatment of pediatric obesity, with evidence supporting their efficacy in reducing body weight, BMI, and improving glycemic control, although gastrointestinal side effects, such as nausea, are common
Finally, in clinical practice, some medications used to treat addiction can also affect appetite and body weight
Stress, insufficient sleep, and aging effects can all take away that healthier radiance you once had